Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies-Reference-Cited by-同舟云学术

Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies

Published:2023-05 Issue: Volume:134 Page:106465
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Jing Lanlan^ORCID,Wei Wenxiu,Meng Bairu,Chantegreil Fabien,Nachon Florian,Martínez Ana,Wu Gaochan,Zhao Huajun,Song Yuning,Kang Dongwei,Brazzolotto Xavier,Zhan Peng,Liu Xinyong

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference46 articles.

1. P.R.-N. Serge Gauthier, José A. Morais, Claire Webster, World Alzheimer Report 2021: Journey through the diagnosis of dementia, Alzheimer’s Disease International, London, England, 2021.

2. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease;Hampel;Brain.,2018

3. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease;Barage;Neuropeptides.,2015

4. The complexity of tau in Alzheimer's disease;Naseri;Neurosci. Lett.,2019

5. Pathological mechanisms and therapeutic strategies for Alzheimer's disease;Ju;Neural Regen. Res.,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Perspectives and Roles of XRD in Drug Discovery: A Review;Current Analytical Chemistry;2024-08

2. Organo Mediated Sustainable Synthesis and In‐Silico Studies of Novel Benzisoxazole‐Chromene Acyl Hydrazones as AChE Inhibitors;ChemistrySelect;2024-06-18

3. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

4. Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease;ACS Chemical Neuroscience;2024-03-07